1585 related articles for article (PubMed ID: 29329680)
1. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
2. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
[TBL] [Abstract][Full Text] [Related]
3. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
5. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function.
Lin X; Fan Y; Wang X; Chi M; Li X; Zhang X; Sun D
Am J Med Sci; 2017 Oct; 354(4):388-394. PubMed ID: 29078843
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of BPI-ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization.
Tian Y; Zeng T; Tan L; Wu Y; Yu J; Huang J; Pei Z
J Clin Lab Anal; 2019 Jul; 33(6):e22908. PubMed ID: 31106488
[TBL] [Abstract][Full Text] [Related]
8. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-146a/b correlates with inflammatory cytokines in COPD and could predict the risk of acute exacerbation COPD.
Chen BB; Li ZH; Gao S
Medicine (Baltimore); 2018 Feb; 97(7):e9820. PubMed ID: 29443743
[TBL] [Abstract][Full Text] [Related]
10. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?
Sarioglu N; Hismiogullari AA; Bilen C; Erel F
Rev Port Pneumol (2006); 2016; 22(1):11-7. PubMed ID: 26534740
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
Lung; 2008; 186(6):403-9. PubMed ID: 18807087
[TBL] [Abstract][Full Text] [Related]
12. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
13. Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.
Umare V; Pradhan V; Nadkar M; Rajadhyaksha A; Patwardhan M; Ghosh KK; Nadkarni AH
Mediators Inflamm; 2014; 2014():385297. PubMed ID: 25548434
[TBL] [Abstract][Full Text] [Related]
14. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
[TBL] [Abstract][Full Text] [Related]
15. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
16. Severity of COPD and its relationship with IL-10.
Silva BSA; Lira FS; Ramos D; Uzeloto JS; Rossi FE; Freire APCF; Silva RN; Trevisan IB; Gobbo LA; Ramos EMC
Cytokine; 2018 Jun; 106():95-100. PubMed ID: 29108795
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
18. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH
Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569
[TBL] [Abstract][Full Text] [Related]
19. Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome.
Huang AX; Lu LW; Liu WJ; Huang M
Med Sci Monit; 2016 Aug; 22():2800-8. PubMed ID: 27501772
[TBL] [Abstract][Full Text] [Related]
20. [The effect of glucocorticoid on IL-8 expressing in lung tissue of rat with chronic obstructive pulmonary disease].
Zhang Y; Yang SR; Cheng DY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):287-90. PubMed ID: 17441351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
